Our expertise maximizes your success through strategic regulatory adjustments and robust scientific validation.
Mastering NHP Licensing: Regulatory Framework, Strategic Importance, and Our Expedited Approval Process.
We identify the most strategic and efficient pathways to secure approval for your product’s formulation.
Provide tailored recommendations to optimize your formulation, seamlessly aligning regulatory compliance with market appeal.
Precision-driven applications tailored for first-submission approval and rapid market entry.
Evidence-based scientific rationales and data dossiers, meticulously prepared for regulatory compliance.
Precision Bilingual Labeling: Expertly structured text that separates mandatory safety data from optional branding, ensuring total Health Canada compliance.
Final Label Validation: Ensuring every mandatory element and legibility standard meets stringent regulatory requirements.
Our expertise maximizes your product's success by integrating strategic refinements, rigorous scientific validation, and precise regulatory intelligence.
Amendments are required for significant modifications affecting a product’s safety, efficacy, or quality. Such changes necessitate Health Canada approval and a formal license update prior to implementation.
Key examples include updates to:
Medicinal Ingredients: Changes in source material or potency.
Product Specifications: Adjustments to test methods or purity tolerances.
Usage & Dosage: Modifications to recommended dose or duration.
Risk Information: Updates to warnings or adverse reaction statements.
Notifications cover minor updates that do not impact a product’s safety, efficacy, or quality. These updates must be filed with Health Canada within 60 calendar days of implementation.
Standard notifications include:
Brand Identity: Updates to product brand names.
Excipient Changes: Adding or substituting non-medicinal ingredients.
Ingredient Nomenclature: Updating common or proper names of medicinal ingredients.
Safety Enhancements: Adding new warnings or adverse reaction details.
Class 1 Sample
Class 3 Sample
Step 1: Confidentiality Agreement
We begin by signing a Non-Disclosure Agreement (NDA) to ensure all discussions remain confidential. Required information will only be shared with Health Canada for the application process.
Step 2: Submit Formulations
Provide the following details for initial assessment:
Formula information, including the list and amounts of medicinal (active) and non-medicinal (excipient) ingredients.
Dosage directions and dosage form.
Designated selling country.
Designated claimed functions.
Step 3: Compliance Review
We review your documents to ensure your product meets Canadian regulations. If modifications are needed (e.g., dosage adjustments or ingredient changes), we will advise you. For non-compliant products, we will notify you of the likelihood of rejection.
Step 4: Quotation
Upon review, we provide an all-inclusive written quotation detailing the work and timeline required. The quoted amount is final—there are no hidden charges.
Step 5: Authorization and Application Submission
Once the quote is approved:
We will send you a Designated Party Authorization (DPA) Form for signature, allowing us to represent you with Health Canada.
A 70% deposit is required upon signing the DPA.
After receiving the deposit, we will provide you with a detailed Registration Information Checklist outlining the necessary details and documents needed for the application.
Upon receiving the deposit and all required information, we will submit the complete application package according to the timeline specified in the quotation.
Step 6: Responding to Health Canada
During Health Canada's assessment, additional information may be requested. We will collaborate with you to gather the required details and submit responses to Information Request Notices (IRNs) within the specified timeframe. This service is fully included in your package—no additional fees!
Step 7: Submission and Approval
Once the NPN is approved, we will notify you and issue the final invoice for the remaining 30%.
We provide bespoke regulatory solutions tailored to your unique business objectives. By blending deep technical expertise with industry foresight, we de-risk the compliance process—empowering you to scale your brand in the Canadian market with total confidence.
Complete document compilation and expert representation in all Health Canada correspondence.
We provide aaupdates within 1 business day and comprehensive project responses within 3.
Our senior regulatory team architects cost-optimized approval pathways tailored to your product’s specific needs.
Ensure timely execution of your business plans.
Two complimentary notifications within the first nine months post-approval, ensuring your license remains current as your brand evolves.
Maintain continuous compliance with seamless, expert-led management.
We provide end-to-end support, from meticulous QTA reviews and strategic IRN responses to comprehensive post-licensing compliance audits.
Ensure full compliance with Health Canada’s requirements.
The following information is typically required for us to create your NPN application package:
NPN holder’s name and contact information.
Formula details, including all medicinal ingredients and excipients.
The dosage form and dosage.
Desired functional claims.
Other ingredient-specific information (if applicable).
Our team ensures your application is complete, accurate, and meets Health Canada’s standards. We provide:
Pre-submission meeting arrangements and preparation of pre-submission packages.
New company registration and obtaining a company code.
Completion of the Product Licence Applications (PLA) form.
Preparation of Finished Product Specifications.
Label text drafting in compliance with regulatory requirements.
Master File submissions.
Attestation to NNHPD monographs and/or preparation of Scientific Rationale.
Creation of a comprehensive Summary Report.
Assistance with completing the Animal Tissue Form, if applicable.
We assist in identifying and fulfilling all testing requirements to ensure your product meets compliance standards which could include:
Testing requirements depend on your product’s classification and ingredients. Common tests include assays on potency, microbial, and heavy metal contaminants.
Depending on the ingredients and extraction method, additional tests such as aflatoxins, solvent residues, or peroxide value may also be required.
Processing times vary by product complexity and Health Canada’s workload. Typical timelines are:
Class I: 60 calendar days.
Class II: 90 calendar days.
Class III: 180 calendar days for assessment, plus 210 calendar days for processing.
We work efficiently to prepare and submit your application to minimize delays.
Yes, all NHPs sold in Canada must have an NPN. Some platforms, such as Amazon, have stricter requirements, regularly auditing product compliance and flagging non-compliant products.
The NPN application process is complex, requiring navigation through detailed regulations. Our specialists streamline the process, helping you avoid costly errors, expedite review timelines, and maximize approval success.
The brand owner holds the NPN license
No. Once granted, an NPN license remains valid.
Some changes only require a post-license notification or amendment; others may need a new NPN. We’ll guide you on the right path depending on the change.
Timelines vary by class: Class I can be as fast as 60 days, while Class III may take up to 210 days.
Health Canada requires supporting evidence for any claim. This can include published studies, monographs, or clinical data. We’ll help you assess what’s needed.
Timelines depend on product class (1, 2, or 3) and Health Canada service standards. No fast‑track option exists. Starting early is the best way to avoid delays.
No. FDA labels follow U.S. rules, not Canadian ones. To sell in Canada, you need full NHP label compliance with English and French requirements.
No. Health Canada requires full transparency. Each medicinal ingredient and its quantity must be listed in the application and on the label.
Yes. Both English and French must appear in equal font size. Quebec, in particular, enforces strict rules against English‑only labels, which can lead to recalls, fines, or blocked imports.
Not if you use a Health Canada site‑licensed manufacturer and meet all quality requirements.